Psoriasis：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 26
4.3.1 Amgen 26
4.3.2 AbbVie (Abbott) 29
4.3.3 Johnson & Johnson 31
4.3.4 Novartis 33
4.3.5 Pfizer 35
4.3.6 Eli Lilly 37
4.3.7 Merck 39
4.3.8 LEO Pharma 41
4.3.9 Celgene 44
5 Appendix 46
5.1 Bibliography 46
5.2 Abbreviations 47
5.3 Methodology 48
5.4 Forecasting Methodology 48
5.4.1 Diagnosed Psoriasis Patients 48
5.4.2 Percent Drug-Treated Patients 49
5.4.3 Drugs Included in Each Therapeutic Class 49
5.4.4 Launch and Patent Expiry Dates 50
5.4.5 General Pricing Assumptions 51
5.4.6 Individual Drug Assumptions 52
5.4.7 Generic Erosion 56
5.4.8 Pricing of Pipeline agents 56
5.5 Physicians and Specialists Included in this Study 57
5.6 Primary Research – Prescriber Survey 58
5.7 About the Authors 59
5.7.1 Analysts 59
5.7.2 Global Head of Healthcare 60
5.8 About GlobalData 61
5.9 Disclaimer 61